Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD): emphasising the critical phases in the developmental trajectory of gut microbiota

IF 25.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Gut Pub Date : 2024-12-23 DOI:10.1136/gutjnl-2024-333425
Jingwan Zhang
{"title":"Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD): emphasising the critical phases in the developmental trajectory of gut microbiota","authors":"Jingwan Zhang","doi":"10.1136/gutjnl-2024-333425","DOIUrl":null,"url":null,"abstract":"Inflammatory bowel disease (IBD) has emerged as a global disease, affecting individuals of every ethnicity and age groups worldwide.1 It is broadly accepted that the greatest single risk factor for the development of IBD is having an affected family member.2 First-degree relatives (FDRs) of patients with IBD have approximately a 10-fold greater likelihood of developing the disease than the general population. Despite the fact that numerous studies have been deliciated towards exploring the possible determinants that participated in, the underlying aetiology remains elusive. Amalgamation of both genetic predisposition and environmental exposures have been widely recognised as the predominant factors that instigate and drive the course of IBD. On this basis, they may also serve as contributing factors to the familial occurrence of IBD. Given that the family members of patients with IBD represent a specific population enduring this dual challenges over an extended period, it is of great concern to recognise whether undesirable alterations have manifested in these clinically asymptomatic relatives. Among numerous possibilities, changes of gut microbiome may be the overarching mechanism via which these two risk factors mediate their effect on IBD. A comprehensive understanding of gut microbiome alterations among unaffected relatives will advance our elucidation of the complexities underlying the familial aggregation of IBD. In Gut , Jacobs et al examined the gut dysbiosis and consequential functional dysregulation in members from high-risk IBD families with age spectrum from birth to senescence.3 In derivation cohort comprised 387 individuals from multiplex IBD family and 51 individuals from control families, an IBD-associated pattern of gut dysbiosis, which defined from their prior research, was observed among unaffected members from multiplex IBD families. Such dysbiosis manifested from birth with the character of delayed microbiome maturation in infants born to mothers with IBD in the early life. Starting from late …","PeriodicalId":12825,"journal":{"name":"Gut","volume":"40 1","pages":""},"PeriodicalIF":25.8000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2024-333425","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammatory bowel disease (IBD) has emerged as a global disease, affecting individuals of every ethnicity and age groups worldwide.1 It is broadly accepted that the greatest single risk factor for the development of IBD is having an affected family member.2 First-degree relatives (FDRs) of patients with IBD have approximately a 10-fold greater likelihood of developing the disease than the general population. Despite the fact that numerous studies have been deliciated towards exploring the possible determinants that participated in, the underlying aetiology remains elusive. Amalgamation of both genetic predisposition and environmental exposures have been widely recognised as the predominant factors that instigate and drive the course of IBD. On this basis, they may also serve as contributing factors to the familial occurrence of IBD. Given that the family members of patients with IBD represent a specific population enduring this dual challenges over an extended period, it is of great concern to recognise whether undesirable alterations have manifested in these clinically asymptomatic relatives. Among numerous possibilities, changes of gut microbiome may be the overarching mechanism via which these two risk factors mediate their effect on IBD. A comprehensive understanding of gut microbiome alterations among unaffected relatives will advance our elucidation of the complexities underlying the familial aggregation of IBD. In Gut , Jacobs et al examined the gut dysbiosis and consequential functional dysregulation in members from high-risk IBD families with age spectrum from birth to senescence.3 In derivation cohort comprised 387 individuals from multiplex IBD family and 51 individuals from control families, an IBD-associated pattern of gut dysbiosis, which defined from their prior research, was observed among unaffected members from multiplex IBD families. Such dysbiosis manifested from birth with the character of delayed microbiome maturation in infants born to mothers with IBD in the early life. Starting from late …
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在炎症性肠病(IBD)的未受影响的亲属中存在生态失调:强调肠道微生物群发育轨迹的关键阶段
炎症性肠病(IBD)已成为一种全球性疾病,影响着全世界各个种族和年龄组的个体人们普遍认为,IBD发展的最大单一风险因素是有患病的家庭成员IBD患者的一级亲属(fdr)患此病的可能性大约是一般人群的10倍。尽管事实上有许多研究都在探索可能的决定因素,但潜在的病因学仍然难以捉摸。遗传易感性和环境暴露的合并已被广泛认为是煽动和驱动IBD病程的主要因素。在此基础上,它们也可能是IBD家族性发生的促成因素。考虑到IBD患者的家庭成员代表了一个特定的人群,在很长一段时间内承受着这种双重挑战,认识到这些临床无症状的亲属是否表现出不良的改变是非常值得关注的。在众多可能性中,肠道微生物组的变化可能是这两种危险因素介导其对IBD影响的主要机制。全面了解未受影响亲属的肠道微生物组改变将促进我们阐明IBD家族聚集背后的复杂性。在Gut中,Jacobs等人研究了IBD高危家族成员从出生到衰老的肠道生态失调和相应的功能失调在由387名来自多发性IBD家族的个体和51名来自对照家族的个体组成的衍生队列中,在未受影响的多发性IBD家族成员中观察到与IBD相关的肠道生态失调模式,这是由他们之前的研究定义的。在早期患有IBD的母亲所生的婴儿中,这种生态失调从出生开始就表现为微生物群成熟延迟的特征。从晚……
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gut
Gut 医学-胃肠肝病学
CiteScore
45.70
自引率
2.40%
发文量
284
审稿时长
1.5 months
期刊介绍: Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts. As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.
期刊最新文献
Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment. Commonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case-control study. Acute abdomen after endoscopic treatment of caecal angiodysplasia. Diagnostic endoscopic resection for assessing potential residual disease after neoadjuvant therapy for oesophageal adenocarcinoma. Stage-dependent gut microbiome and functional signatures across the liver disease spectrum: an integrative multicohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1